Nifty
Sensex
:
:
9039.25
30672.59
-67.00 (-0.74%)
-260.31 (-0.84%)

Pharmaceuticals & Drugs - API

Rating :
62/99

BSE: 500288 | NSE: MOREPENLAB

15.55
22-May-2020
  • Open
  • High
  • Low
  • Previous Close
  •  15.90
  •  15.95
  •  15.50
  •  15.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  357259
  •  55.98
  •  23.95
  •  7.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 699.48
  • 21.16
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 679.21
  • N/A
  • 2.55

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 34.54%
  • 3.73%
  • 41.13%
  • FII
  • DII
  • Others
  • 0.74%
  • 13.39%
  • 6.47%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 13.75
  • 13.92
  • 8.88

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.23
  • 6.96
  • 1.93

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 68.25
  • 6.88

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.12
  • 46.21
  • 32.30

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.53
  • 4.86
  • 4.32

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.79
  • 16.24
  • 14.53

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Net Sales
230.06
212.16
8.44%
213.43
173.94
22.70%
202.98
163.73
23.97%
218.72
171.46
27.56%
Expenses
214.75
195.32
9.95%
198.37
157.17
26.21%
183.65
151.55
21.18%
196.97
153.61
28.23%
EBITDA
15.30
16.83
-9.09%
15.06
16.76
-10.14%
19.33
12.18
58.70%
21.75
17.85
21.85%
EBIDTM
6.65%
7.93%
7.05%
9.64%
9.52%
7.44%
9.94%
10.41%
Other Income
4.60
2.43
89.30%
2.81
0.13
2,061.54%
0.28
0.08
250.00%
1.03
0.30
243.33%
Interest
0.54
0.43
25.58%
0.39
0.32
21.88%
0.43
0.44
-2.27%
0.93
0.81
14.81%
Depreciation
8.54
9.80
-12.86%
8.24
9.79
-15.83%
11.50
9.16
25.55%
11.15
10.39
7.31%
PBT
10.82
9.04
19.69%
9.24
6.79
36.08%
7.68
2.65
189.81%
10.70
6.96
53.74%
Tax
0.01
0.13
-92.31%
5.15
-0.19
-
0.02
0.19
-89.47%
0.21
-0.03
-
PAT
10.82
8.91
21.44%
4.09
6.97
-41.32%
7.66
2.46
211.38%
10.49
6.99
50.07%
PATM
4.70%
4.20%
1.92%
4.01%
3.77%
1.50%
4.80%
4.08%
EPS
0.24
0.20
20.00%
0.09
0.16
-43.75%
0.17
0.05
240.00%
0.23
0.15
53.33%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
865.19
768.54
606.51
595.47
485.08
400.64
366.85
325.92
289.34
228.30
211.86
Net Sales Growth
19.95%
26.72%
1.85%
22.76%
21.08%
9.21%
12.56%
12.64%
26.74%
7.76%
 
Cost Of Goods Sold
570.89
479.12
361.28
358.35
293.33
238.62
209.04
193.53
178.07
142.68
127.05
Gross Profit
294.30
289.42
245.23
237.12
191.76
162.02
157.81
132.39
111.27
85.62
84.80
GP Margin
34.02%
37.66%
40.43%
39.82%
39.53%
40.44%
43.02%
40.62%
38.46%
37.50%
40.03%
Total Expenditure
793.74
701.02
541.78
534.09
423.52
352.41
317.95
294.97
270.11
222.53
200.23
Power & Fuel Cost
-
13.18
11.08
9.84
7.64
7.41
8.42
8.96
9.82
7.69
6.01
% Of Sales
-
1.71%
1.83%
1.65%
1.57%
1.85%
2.30%
2.75%
3.39%
3.37%
2.84%
Employee Cost
-
95.36
76.53
69.69
58.29
48.79
45.08
39.17
36.05
30.52
23.48
% Of Sales
-
12.41%
12.62%
11.70%
12.02%
12.18%
12.29%
12.02%
12.46%
13.37%
11.08%
Manufacturing Exp.
-
31.28
16.21
22.36
13.33
12.68
12.23
11.33
10.20
11.40
9.19
% Of Sales
-
4.07%
2.67%
3.76%
2.75%
3.16%
3.33%
3.48%
3.53%
4.99%
4.34%
General & Admin Exp.
-
36.14
28.52
18.11
18.14
15.89
16.62
13.86
14.37
12.72
13.24
% Of Sales
-
4.70%
4.70%
3.04%
3.74%
3.97%
4.53%
4.25%
4.97%
5.57%
6.25%
Selling & Distn. Exp.
-
32.73
30.04
25.79
23.45
21.40
19.55
20.40
15.85
11.26
18.13
% Of Sales
-
4.26%
4.95%
4.33%
4.83%
5.34%
5.33%
6.26%
5.48%
4.93%
8.56%
Miscellaneous Exp.
-
13.20
18.11
29.95
9.35
7.61
7.01
7.72
5.75
6.26
18.13
% Of Sales
-
1.72%
2.99%
5.03%
1.93%
1.90%
1.91%
2.37%
1.99%
2.74%
1.47%
EBITDA
71.44
67.52
64.73
61.38
61.56
48.23
48.90
30.95
19.23
5.77
11.63
EBITDA Margin
8.26%
8.79%
10.67%
10.31%
12.69%
12.04%
13.33%
9.50%
6.65%
2.53%
5.49%
Other Income
8.72
3.67
3.72
3.72
1.20
1.37
1.22
2.87
1.18
1.04
0.33
Interest
2.29
2.11
4.36
7.56
10.50
8.66
9.92
11.63
7.96
6.27
4.03
Depreciation
39.43
39.90
34.32
33.90
35.20
38.67
45.84
45.80
48.06
48.16
48.02
PBT
38.44
29.18
29.77
23.63
17.06
2.28
-5.64
-23.61
-35.61
-47.62
-40.10
Tax
5.39
0.34
0.00
0.00
-0.13
0.14
0.01
-0.01
0.06
-0.69
0.03
Tax Rate
14.02%
1.17%
0.00%
0.00%
-1.03%
6.14%
-0.36%
0.05%
-0.25%
1.45%
-0.48%
PAT
33.06
28.85
29.59
23.63
12.80
2.14
-2.77
-20.52
-23.65
-46.93
-6.22
PAT before Minority Interest
33.06
28.84
29.77
23.63
12.80
2.14
-2.75
-20.52
-23.63
-46.93
-6.27
Minority Interest
0.00
0.01
-0.18
0.00
0.00
0.00
-0.02
0.00
-0.02
0.00
0.05
PAT Margin
3.82%
3.75%
4.88%
3.97%
2.64%
0.53%
-0.76%
-6.30%
-8.17%
-20.56%
-2.94%
PAT Growth
30.52%
-2.50%
25.22%
84.61%
498.13%
-
-
-
-
-
 
Unadjusted EPS
0.73
0.64
0.66
0.53
0.28
0.04
-0.07
-0.45
-0.54
-1.04
-0.15

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
253.09
225.94
196.26
300.28
287.48
297.11
299.88
320.40
344.05
390.99
Share Capital
89.96
89.96
89.96
209.61
209.61
209.61
209.61
209.61
209.61
209.61
Total Reserves
163.13
135.98
106.30
90.67
77.87
87.50
90.27
110.79
134.44
181.38
Non-Current Liabilities
23.38
20.20
17.80
57.47
74.00
84.65
103.91
122.05
135.01
139.74
Secured Loans
1.83
2.95
1.38
43.41
62.27
74.78
94.65
98.85
114.37
128.45
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
15.04
14.32
11.29
Long Term Provisions
19.01
14.42
13.59
11.34
9.22
7.82
7.17
5.73
3.90
0.00
Current Liabilities
339.17
340.12
324.86
166.56
127.92
108.14
102.73
104.95
102.78
85.24
Trade Payables
168.15
174.88
124.88
115.33
84.96
68.60
56.81
64.98
59.79
82.18
Other Current Liabilities
160.64
163.90
198.65
47.04
39.87
37.58
45.22
38.96
41.11
0.00
Short Term Borrowings
8.99
0.00
0.00
0.00
2.23
1.19
0.00
0.00
0.00
0.00
Short Term Provisions
1.39
1.33
1.33
4.19
0.86
0.77
0.70
1.01
1.88
3.06
Total Liabilities
615.18
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40
615.53
Net Block
236.21
264.29
271.80
296.72
322.48
368.08
409.46
451.86
496.02
540.18
Gross Block
887.76
997.60
1,026.96
1,018.43
1,009.35
1,004.61
1,000.44
997.38
997.96
995.54
Accumulated Depreciation
651.55
733.31
755.15
721.72
686.87
636.53
590.98
545.52
501.94
455.35
Non Current Assets
315.71
342.37
346.34
366.53
374.42
393.18
415.00
457.37
501.38
544.15
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
3.87
3.87
3.97
3.97
Long Term Loans & Adv.
79.22
77.81
73.69
69.82
51.94
25.10
1.67
1.64
1.39
0.00
Other Non Current Assets
0.28
0.27
0.85
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
299.47
243.44
191.95
157.15
114.58
96.32
91.09
89.61
80.02
69.96
Current Investments
0.02
0.22
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
94.20
76.89
64.66
42.14
37.11
33.30
37.05
38.66
34.70
31.68
Sundry Debtors
133.75
121.85
92.95
87.94
56.14
42.67
39.11
35.15
29.64
23.83
Cash & Bank
32.21
5.95
7.59
4.36
8.85
9.11
5.53
4.51
2.58
1.10
Other Current Assets
39.29
5.62
4.71
5.94
12.48
11.24
9.40
11.29
13.10
13.34
Short Term Loans & Adv.
31.43
32.92
22.03
16.77
9.34
8.23
6.23
9.60
10.30
11.19
Net Current Assets
-39.70
-96.68
-132.92
-9.41
-13.34
-11.82
-11.64
-15.34
-22.76
-15.28
Total Assets
615.18
585.81
538.29
523.68
489.00
489.50
506.09
546.98
581.40
615.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
17.37
63.41
40.73
50.07
50.70
33.52
33.64
27.11
11.13
6.67
PBT
29.18
29.77
23.04
17.06
2.28
-5.64
-23.60
-35.61
-47.62
-40.10
Adjustment
40.33
38.64
41.40
45.69
47.32
55.76
56.80
55.99
54.44
51.68
Changes in Working Capital
-51.79
-5.00
-23.72
-8.41
1.23
-19.50
-2.64
-5.25
3.63
-4.50
Cash after chg. in Working capital
17.71
63.41
40.73
54.34
50.83
30.62
30.56
15.13
10.45
7.08
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.34
0.00
0.00
0.13
-0.13
0.01
0.01
-0.06
0.68
-0.03
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
-4.40
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-13.05
-26.93
-13.60
-27.30
-31.65
-0.80
-2.83
-3.35
-4.05
-4.43
Net Fixed Assets
113.16
31.96
-8.08
-7.02
-4.73
-4.09
-2.87
0.60
-2.41
-4.29
Net Investments
0.20
-0.22
0.00
0.25
0.00
3.87
0.00
0.10
0.00
0.00
Others
-126.41
-58.67
-5.52
-20.53
-26.92
-0.58
0.04
-4.05
-1.64
-0.14
Cash from Financing Activity
-0.44
-37.77
-23.72
-27.26
-19.31
-29.14
-29.79
-21.83
-5.60
-5.72
Net Cash Inflow / Outflow
3.88
-1.29
3.40
-4.49
-0.26
3.58
1.02
1.93
1.48
-3.48
Opening Cash & Equivalents
5.72
7.00
3.60
8.85
9.11
5.53
4.51
2.58
1.10
4.59
Closing Cash & Equivalent
9.60
5.72
7.00
4.36
8.85
9.11
5.53
4.51
2.58
1.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
5.63
5.02
4.36
4.02
3.73
3.95
4.01
4.46
4.99
6.00
ROA
4.80%
5.30%
4.45%
2.53%
0.44%
-0.55%
-3.90%
-4.19%
-7.84%
-0.99%
ROE
12.04%
14.10%
12.54%
7.35%
1.24%
-1.54%
-10.77%
-11.12%
-18.99%
-2.86%
ROCE
12.38%
14.05%
10.18%
6.29%
2.90%
1.80%
-2.09%
-3.40%
-8.22%
-0.40%
Fixed Asset Turnover
0.82
0.60
0.58
0.49
0.41
0.37
0.33
0.29
0.23
0.21
Receivable days
60.70
64.63
55.44
53.22
44.17
40.16
40.83
40.35
42.17
38.81
Inventory Days
40.63
42.59
32.73
29.27
31.48
34.55
41.63
45.68
52.36
46.50
Payable days
88.85
103.38
82.97
83.88
76.01
67.69
69.30
75.59
101.91
124.72
Cash Conversion Cycle
12.48
3.85
5.20
-1.39
-0.36
7.02
13.16
10.44
-7.39
-39.41
Total Debt/Equity
0.05
0.06
0.25
0.22
0.28
0.30
0.37
0.38
0.39
0.36
Interest Cover
14.83
7.83
4.13
2.21
1.26
0.72
-0.77
-1.96
-6.59
-0.55

News Update:


  • Morepen Laboratories gets ISO-13485 certification for Baddi medical devices manufacturing facility
    30th Apr 2020, 11:04 AM

    The certification has been awarded for the manufacturing, distribution and after sales service of all point-of-care diagnostic medical devices and their accessories

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.